JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PENG
1576
Penguin Solutions Inc
PENG
$3.11B
| $14M | ﹤0.01% |
1,028,504
+206,282
| +25% | +$2.63M |
2017 Q3
11 quarters
|
|
1577
Vanguard FTSE All-World ex-US ETF
VEU
$69.2B
| $13.9M | ﹤0.01% |
292,779
+20,142
| +7% | +$902K |
2013 Q2
28 quarters
|
|
|
ARNA
1578
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $13.9M | ﹤0.01% |
220,616
-81,657
| -27% | -$4.49M |
2016 Q4
14 quarters
|
|
1579
iShares ESG Aware MSCI EM ETF
ESGE
$7.12B
| $13.9M | ﹤0.01% |
433,129
+70,207
| +19% | +$2.11M |
2017 Q4
10 quarters
|
|
1580
CALL
Teva Pharmaceutical Industries Limited
TEVA
$46.3B
| $13.9M | ﹤0.01% |
1,124,000
| – | – |
2019 Q1
5 quarters
|
|
1581
AstraZeneca
AZN
$243B
| $13.8M | ﹤0.01% |
130,815
-119,284
| -48% | -$12.3M |
2013 Q2
28 quarters
|
|
|
DOOR
1582
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $13.8M | ﹤0.01% |
177,512
-74,420
| -30% | -$4.51M |
2014 Q4
22 quarters
|
|
|
LVGO
1583
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $13.8M | ﹤0.01% |
183,588
+32,753
| +22% | +$1.71M |
2019 Q3
3 quarters
|
|
1584
Omnicom Group
OMC
$20.6B
| $13.8M | ﹤0.01% |
252,608
-259,335
| -51% | -$14.1M |
2013 Q2
28 quarters
|
|
1585
Imperial Oil
IMO
$59.7B
| $13.8M | ﹤0.01% |
858,278
-6,308
| -0.7% | -$94.8K |
2013 Q2
28 quarters
|
|
1586
Malibu Boats
MBUU
$448M
| $13.7M | ﹤0.01% |
264,221
-63,899
| -19% | -$2.55M |
2014 Q1
25 quarters
|
|
1587
SouthState Bank Corp
SSB
$9.81B
| $13.7M | ﹤0.01% |
287,624
+17,498
| +6% | +$914K |
2014 Q3
23 quarters
|
|
|
BBBY
1588
DELISTED
Bed Bath & Beyond Inc
BBBY
| $13.7M | ﹤0.01% |
1,290,087
+571,688
| +80% | +$3.94M |
2013 Q2
28 quarters
|
|
1589
Affiliated Managers Group
AMG
$9.84B
| $13.7M | ﹤0.01% |
183,207
+59,720
| +48% | +$4.04M |
2013 Q2
28 quarters
|
|
1590
Cenovus Energy
CVE
$58B
| $13.7M | ﹤0.01% |
2,924,189
-765,882
| -21% | -$2.94M |
2013 Q2
28 quarters
|
|
1591
Fortive
FTV
$17.3B
| $13.6M | ﹤0.01% |
319,584
-7,819
| -2% | -$305K |
2016 Q3
15 quarters
|
|
1592
F5
FFIV
$26B
| $13.6M | ﹤0.01% |
97,711
+4,052
| +4% | +$546K |
2013 Q2
28 quarters
|
|
1593
PUT
Applied Materials
AMAT
$430B
| $13.6M | ﹤0.01% |
225,000
-75,000
| -25% | -$4.05M |
2018 Q4
6 quarters
|
|
1594
CALL
Akebia Therapeutics
AKBA
$252M
| $13.6M | ﹤0.01% |
1,000,000
| – | – |
2019 Q2
4 quarters
|
|
1595
Ryanair
RYAAY
$28.3B
| $13.5M | ﹤0.01% |
510,050
-2,089,968
| -80% | -$52.9M |
2013 Q2
28 quarters
|
|
|
BKI
1596
DELISTED
Black Knight, Inc. Common Stock
BKI
| $13.5M | ﹤0.01% |
186,337
+92,479
| +99% | +$6.56M |
2015 Q4
18 quarters
|
|
1597
CALL
PayPal
PYPL
$46.5B
| $13.5M | ﹤0.01% |
77,600
-53,400
| -41% | -$7.38M |
2015 Q3
19 quarters
|
|
|
HSII
1598
DELISTED
Heidrick & Struggles
HSII
| $13.5M | ﹤0.01% |
624,852
+48,395
| +8% | +$1.07M |
2013 Q2
28 quarters
|
|
|
CFXA
1599
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $13.5M | ﹤0.01% |
110,678
-3,800
| -3% | -$430K |
2019 Q1
5 quarters
|
|
1600
PUT
Newmont
NEM
$122B
| $13.5M | ﹤0.01% |
218,500
-272,000
| -55% | -$16.1M |
2014 Q2
24 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.